Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: PHARMALEX US CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-04-15 to 2024-04-14
Current total value of award: $54225
Description: BIOLOGICS SUBJECT MATTER EXPERT (SME) CONSULTING SERVICES